Gaetano Corazzelli - Concepedia

Author

Gaetano Corazzelli

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"ORCID

Also Known As

G Corazzelli, G. Corazzelli, Gaetano Corazzelli

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"Federico II University Hospital San Raffaele University of Rome Azienda Ospedaliero Universitaria San Giovanni Battista Ospedale Bellaria

About

Gaetano Corazzelli is an author at Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" specializing in oncology, medicine, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	866
2	Immunology	3	3	169
3	Health Sciences	2	2	719
4	Pathology	2	2	72
5	Pharmacology	1	1	31

Gaetano Corazzelli

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial Andrés JM Ferreri, Michele Reni, Marco Foppoli, The Lancet Hematological MalignancyNeuro-oncologyLymphoid NeoplasiaMedicinePrimary Cns Lymphoma	2009	656
Temozolomide as salvage treatment in primary brain lymphomas Michele Reni, Francesco Zaja, Warren Mason, British Journal of Cancer	2007	178
MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas Andrés J.M. Ferreri, Stefania Dell’Oro, Marco Foppoli, Neurology	2006	93
RD‐CODOX‐M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and ‘unclassifiable’ highly aggressive B‐cell lymphoma Gaetano Corazzelli, Ferdinando Frigeri, Filippo Russo, British Journal of Haematology	2011	76
Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma Gaetano Corazzelli, Gaetana Capobianco, Manuela Arcamone, Cancer Chemotherapy and Pharmacology B-cell LymphomaLymphoid NeoplasiaHematological MalignancyTransplantationMedicine	2009	75
Efficacy and safety of bendamustine for the treatment of patients with recurring <scp>H</scp>odgkin lymphoma Gaetano Corazzelli, F. Angrilli, Alfonso Maria D’Arco, British Journal of Haematology ImmunologyPharmacotherapyMetronomic ChemotherapyImmunotherapyBendamustine Hydrochloride	2012	63
Biweekly rituximab, cyclophosphamide, vincristine, non‐pegylated liposome‐encapsulated doxorubicin and prednisone (R‐COMP‐14) in elderly patients with poor‐risk diffuse large B‐cell lymphoma and moderate to high ‘life threat’ impact cardiopathy Gaetano Corazzelli, Ferdinando Frigeri, Manuela Arcamone, British Journal of Haematology	2011	58
MATILDE chemotherapy regimen for primary CNS lymphoma Andrés J.M. Ferreri, Fabio Ciceri, Alba A. Brandes, Neurology	2014	43
Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot study Gaetano Corazzelli, Filippo Russo, Giampiero Capobianco, Annals of Oncology Lymphoid NeoplasiaRefractory Aggressive Non-hodgkinMedicinePathologyCancer Treatment	2006	41
Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination Andrés J.M. Ferreri, Giada Licata, Marco Foppoli, The Oncologist	2011	33

Page 1